• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Ardelyx, Inc. - Common Stock (NQ:ARDX)

    5.380 -0.040 (-0.74%)
    Streaming Delayed Price Updated: 1:38 PM EDT, Jun 4, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,308,238
    Open 5.500
    Bid (Size) 5.380 (2,300)
    Ask (Size) 5.390 (5,100)
    Prev. Close 5.420
    Today's Range 5.380 - 5.545
    52wk Range 3.490 - 8.400
    Shares Outstanding 103,119,010
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Ardelyx Eyes $500M+ Revenue as IBSRELA Growth Puts Profitability Within Reach ↗
    Ardelyx (NASDAQ:ARDX) executives said at the Jefferies Global Healthcare Conference that the company is focused on expanding demand for its commercial products, IBSRELA and XPHOZAH, while continuing to... 
    Via MarketBeat
    News headline image
    Ardelyx to Participate at the Jefferies Global Healthcare Conference 2026
    From Ardelyx, Inc.
    Via GlobeNewswire

    Performance

    YTD
    -12.5%
    -12.5%
    1 Month
    -26.3%
    -26.3%
    3 Month
    -19.1%
    -19.1%
    6 Month
    -6.8%
    -6.8%
    1 Year
    +36.9%
    +36.9%

    More News

    Read More
    News headline image
    Ardelyx Presents Analysis Supporting Long-Term Safety of XPHOZAH at NKF’s Spring Clinical Meetings
    From Ardelyx, Inc.
    Via GlobeNewswire
    News headline image
    Ardelyx (ARDX) Q1 2026 Earnings Transcript ↗
    Via The Motley Fool
    Topics Intellectual Property
    Ardelyx Inc (NASDAQ:ARDX) Reports Strong Q1 Revenue Beat as IBSRELA Momentum Accelerates ↗
    Via Chartmill
    Ardelyx Inc (NASDAQ:ARDX) Reports Q4 2025 Revenue Beat but EPS Miss, Shares Fall ↗
    Via Chartmill
    News headline image
    Ardelyx Reports First Quarter 2026 Financial Results and Provides Business Update
    From Ardelyx, Inc.
    Via GlobeNewswire
    News headline image
    Ardelyx Announces Abstract Accepted for Poster Presentation at the NKF’s Spring Clinical Meetings
    From Ardelyx, Inc.
    Via GlobeNewswire
    News headline image
    Ardelyx Announces Abstract Exploring IBS-C Treatment Patterns Accepted for Poster Presentation at Digestive Disease Week 2026
    From Ardelyx, Inc.
    Via GlobeNewswire
    News headline image
    Ardelyx Appoints Biopharmaceutical Veteran, Felecia W. Ettenberg, as Chief Legal Officer
    From Ardelyx, Inc.
    Via GlobeNewswire
    News headline image
    Ardelyx to Report First Quarter 2026 Financial Results on April 30, 2026
    From Ardelyx, Inc.
    Via GlobeNewswire
    News headline image
    Ardelyx President and CEO Sells 41,000 Shares for $243,000 ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Rajani Dinavahi, MD, Appointed Chief Medical Officer of Ardelyx
    From Ardelyx, Inc.
    Via GlobeNewswire
    News headline image
    Ardelyx Announces Recipients of the 2026 Derek Forfang Patient Advocate Award
    From Ardelyx, Inc.
    Via GlobeNewswire
    News headline image
    Ardelyx Announces Publication of a Review Article Demonstrating Rapid and Meaningful Symptom Relief with Tenapanor in IBS-C
    From Ardelyx, Inc.
    Via GlobeNewswire
    News headline image
    Ardelyx to Participate in Upcoming Investor Conferences
    From Ardelyx, Inc.
    Via GlobeNewswire
    News headline image
    Ardelyx CEO Sells 41k Shares as Company Announces Huge Partnership ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Ardelyx and the LPGA Announce Multi-Year Partnership to Break Stigma Around Digestive Health Issues Impacting Millions
    From Ardelyx, Inc.
    Via GlobeNewswire
    News headline image
    ARDX Stock Jumps Over 5% Overnight As Director Loads Up In Vote Of Confidence For Flagship Constipation Drug ↗
    Via Stocktwits
    News headline image
    Nasdaq, S&P 500 Futures Fall On Tariff, Iran Tensions: Why NVDA, NFLX, HON, IBRX, MLTX Are On Traders' Radar Today ↗
    Via Stocktwits
    Topics Artificial Intelligence ETFs Government
    News headline image
    ARDX Stock Is Down Pre-Market After Q4 Earnings Miss, So Why Did This Firm Just Hike Price Target By 80%? ↗
    Via Stocktwits
    Topics Earnings Intellectual Property
    News headline image
    ARDX Stock Slips After Hours As Q4 Earnings Disappoint: Retail Sees Ibsrela Driving Outperformance In Time ↗
    Via Stocktwits
    Topics Artificial Intelligence
    News headline image
    Ardelyx Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
    From Ardelyx, Inc.
    Via GlobeNewswire
    News headline image
    Ardelyx to Report Full Year and Fourth Quarter 2025 Financial Results on February 19, 2026
    From Ardelyx, Inc.
    Via GlobeNewswire
    News headline image
    Ardelyx Receives New Patent for Tenapanor
    From Ardelyx, Inc.
    Via GlobeNewswire

    Frequently Asked Questions

    Is Ardelyx, Inc. - Common Stock publicly traded?
    Yes, Ardelyx, Inc. - Common Stock is publicly traded.
    What exchange does Ardelyx, Inc. - Common Stock trade on?
    Ardelyx, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Ardelyx, Inc. - Common Stock?
    The ticker symbol for Ardelyx, Inc. - Common Stock is ARDX on the Nasdaq Stock Market
    What is the current price of Ardelyx, Inc. - Common Stock?
    The current price of Ardelyx, Inc. - Common Stock is 5.380
    When was Ardelyx, Inc. - Common Stock last traded?
    The last trade of Ardelyx, Inc. - Common Stock was at 06/04/26 01:38 PM ET
    What is the market capitalization of Ardelyx, Inc. - Common Stock?
    The market capitalization of Ardelyx, Inc. - Common Stock is 554.78M
    How many shares of Ardelyx, Inc. - Common Stock are outstanding?
    Ardelyx, Inc. - Common Stock has 555M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.